TY - JOUR ID - 147963 TI - Relationship between blood albumin level and clinical condition of patients with Covid-19 admitted to Shahid Sadoughi hospital in Yazd JO - Health Biotechnology and Biopharma (HBB) JA - HBB LA - en SN - AU - Hamidfar, Mahdie AU - shahcheraghi, Seyed Hossein AU - Heidari, Faezehsadat AU - Ansari, Kazem AU - Fallah, Tahere AD - Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran AD - MD, Nano-Biotech Foresight Company Biotechnology Campus, Yazd Stem Cells and Regenerative Medicine Institute, Yazd, Iran AD - Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Y1 - 2022 PY - 2022 VL - 6 IS - 1 SP - 26 EP - 32 KW - COVID-19 KW - Serum albumin KW - clinical status DO - 10.22034/HBB.2022.09 N2 - COVID-19 infection is still widespread around the world. It has been demonstrated that albumin is a biomarker in COVID-19 diagnosis. The aim of this study was to investigate the relationship between blood albumin and clinical status of COVID-19 patients. In our study, patients older than 18 years admitted to a hospital in Yazd with a positive PCR test participated. Related data was analyzed by SPSS software. 34.2 % of the men with lower than normal albumin levels needed to be admitted to the ICU. Also, 32.8 % of the women with lower than normal albumin levels needed to be admitted to the ICU. The results of the present study showed that the patients with lower serum albumin needed to be admitted to the ICU more than other patients. UR - https://www.healthbiotechpharm.org/article_147963.html L1 - https://www.healthbiotechpharm.org/article_147963_0f296a3d1035fb5db9856fc010b03414.pdf ER -